Advertisement
News
Subscribe to MDT Magazine News

Accuray Incorporated's CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference

December 28, 2010 8:35 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Dec. 28, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its president and chief executive officer, Euan S. Thomson, Ph.D., is scheduled to present at the 29th Annual J.P. Morgan Healthcare Conference in...

TOPICS:

ASU technology to treat chronic respiratory diseases

December 28, 2010 8:34 am | by Arizona State University | Comments

Miniature sensor technology developed at ASU's Biodesign Institute will be used to develop medical devices to better treat chronic respiratory diseases such as asthma.read more

TOPICS:

Purdue, NIST working on breathalyzers for medical diagnostics

December 28, 2010 8:33 am | by EurekAlert | Comments

(Purdue University) Researchers have overcome a fundamental obstacle in developing breath-analysis technology to rapidly diagnose patients by detecting chemical compounds called "biomarkers" in a person's respiration in real time.

TOPICS:
Advertisement

Tivorsan makes key DMD therapy development

December 28, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Tivorsan Pharmaceuticals, a protein therapeutics firm in Providence, R.I., has shown that mice with Duchenne Muscular Dystrophy have had improved muscle function due to biglycan protein, according to a news release today from the company.

Case Western Reserve receives $10M to study retinal disease, develop new treatments

December 28, 2010 6:40 am | by EurekAlert | Comments

(Case Western Reserve University) The Departments of Pharmacology and Ophthalmology and Visual Sciences at Case Western Reserve University School of Medicine have been awarded a $10.1 million grant from the National Eye Institute to research and develop new treatments for diseases...

TOPICS:

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Third Party Review Program...(3)

December 28, 2010 6:39 am | by U.S. Food & Drug Administration | Comments

Section 210 of the FDAMA established section 523 of the FD&C Act (21 U.S.C. 360m), directing FDA to accredit persons in the private sector to review certain premarket notifications (510(k)s). Participation in this third-party review program by...

HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication

December 28, 2010 6:38 am | by Bio-Medicine.Org | Comments

FRAMINGHAM, Mass. and SYDNEY, Dec. 28, 2010 /- HeartWare International, Inc. (Nasdaq: HTWR ; ASX: HIN) today announced that it has submitted a Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the HeartWare® Ventricular Assist System as a bridge...

TOPICS:

Medco Extends URAC Accreditation to Drug Therapy Management, PBM

December 28, 2010 6:38 am | by Bio-Medicine.Org | Comments

FRANKLIN LAKES, N.J., Dec. 28, 2010 /- Medco Health Solutions, Inc., (NYSE: MHS ) today announced that URAC, one of the nation's leading independent health care quality evaluators, has accredited Medco's Pharmacy Benefit Management and Drug Therapy Management (DTM) programs, recognizing...

TOPICS:
Advertisement

Federal Register: Request for Notification From Consumer Organizations Interested in Participating in the Selection Process for Nominations for Voting and/or NV Consumer Repre...

December 28, 2010 6:34 am | by U.S. Food & Drug Administration | Comments

The FDA is requesting that any consumer organizations interested in participating in the selection of voting and/or nonvoting consumer representatives to serve on its advisory committees or panels notify FDA in writing.

TOPICS:

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Third Party Review Program...

December 28, 2010 6:31 am | Comments

[Federal Register: December 28, 2010 (Volume 75, Number 248)] [Notices] [Page 81616-81617] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr28de10-116] ----------------------------------------------------------------------- DEPARTMENT O

Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Third Party Review Program...(2)

December 28, 2010 6:31 am | by U.S. Food & Drug Administration | Comments

Section 210 of the FDAMA established section 523 of the FD&C Act (21 U.S.C. 360m), directing FDA to accredit persons in the private sector to review certain premarket notifications (510(k)s). Participation in this third-party review program by...

TOPICS:

FDA needs 4 more weeks for to review MannKind drug

December 28, 2010 2:45 am | by The Associated Press | Comments

MannKind Corp. said Tuesday the Food and Drug Administration will take an additional four weeks to review the application for the inhaled insulin Afrezza.The agency had initially expected to make a decision by Wednesday.MannKind had asked for approval of the product in March 2009, but the...

Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai

December 28, 2010 1:31 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, Dec. 28, 2010 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ), ("Winner Medical") a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today reported that a...

TOPICS:

Sun Healthcare Group, Inc. to Present at the 29th Annual J.P. Morgan Healthcare Conference

December 27, 2010 11:45 am | by The Associated Press | Comments

Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced that William A. Mathies, the company's chairman and chief executive officer, and L. Bryan Shaul, the company's chief financial officer, will present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2011, at...

Functional Technologies Corporation Retains Pathfinder Ventures Corporation to Provide Investor Relations Services

December 27, 2010 9:45 am | by The Associated Press | Comments

http://www.functionaltechcorp.com () —Functional Technologies Corporation (TSX VENTURE: FEB) is pleased to announce that it has retained the services of Pathfinder Ventures Corporation ("Pathfinder"), of Vancouver, BC, to provide investor relations services, subject to regulatory approval....

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading